BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition ...
Boston Scientific (NYSE:BSX) is set to announce its earnings on Wednesday, July 23, 2025. In the last five years, BSX stock has shown a positive return on the day after earnings announcements in 60% ...
We came across a bullish thesis on Boston Scientific Corporation (BSX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BSX. Boston Scientific Corporation (BSX)’s ...
Boston Scientific (NYSE: BSX) is scheduled to report its Q2 2024 results on Wednesday, July 24. We expect the company to report revenues and earnings in line with the consensus estimates. A rise in ...
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund returned 2.54% ...
Boston Scientific (BSX) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to earnings of $0.62 per share a year ago. These ...
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks presents investors with the ...
Zacks Investment Research on MSN
BSX vs. RMD: Which medical device stock is the stronger play now?
Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback